Inovio Pharmaceuticals, Inc. (INO) financial statements and ratios from SEC XBRL: revenue $65343.00 (TTM), net margin -130000.0%, revenue growth -70.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $65343.00 |
| Net Margin | -130000.0% |
| Revenue Growth (YoY) | -70.0% |
| EPS Growth (YoY) | -54.2% |
| FCF Growth (YoY) | -15.0% |
| Price / Book | 27.91 |
| FCF Yield | -124.8% |
| Altman Z-Score | -36.80 (distress) |
| Sector P/E (Healthcare) | 21.7 |
INO overview · INO earnings · INO KPIs · INO investor relations · INO ownership · INO peers · INO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.